Is it appropriate to reduce the frequency of tralokinumab in patients who respond to the medication?
Featuring Tina Bhutani, MD, MAS |

Associate Professor, Department of Dermatology
University of California
San Francisco, CA

| Published February 16, 2023
Loading...
Loading...
Loading...
Dermsquared

The leading platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved